Usefulness of Serum Omentin-1 Levels for the Prediction of Adverse Cardiac Events in Patients with Hypertrophic Cardiomyopathy (original) (raw)
Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure
Tetsu Watanabe
Cardiovascular Diabetology, 2014
View PDFchevron_right
Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy
Venkatakrishna Tholakanahalli
Circulation, 2004
View PDFchevron_right
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy
Franco Cecchi
The American Journal of Cardiology, 2013
View PDFchevron_right
Usefulness of Brain Natriuretic Peptide Levels in the Clinical Evaluation of Patients With Hypertrophic Cardiomyopathy
Ahsan Safdar
The American Journal of Cardiology, 2007
View PDFchevron_right
Plasma N-Terminal Pro-Brain Natriuretic Peptide is a sensitive marker of functional severity in hypertrophic cardiomyopathy
Edmundo Arteaga
Journal of Cardiac Failure, 2004
View PDFchevron_right
Determinants and clinical significance of natriuretic peptides and hypertrophic cardiomyopathy
Carlo Gabriele Tocchetti
European Heart Journal, 2001
View PDFchevron_right
Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study
Morimasa Takayama
BMJ open, 2014
View PDFchevron_right
Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction
Seung-woo Yu
Clinical Cardiology, 2006
View PDFchevron_right
Plasma amino-terminal pro–B-type natriuretic peptide quantification in hypertrophic cardiomyopathy
Rogerio Rabelo
American Heart Journal, 2005
View PDFchevron_right
Plasma Pro-B-Type Natriuretic Peptide Testing as a Screening Method for Hypertrophic Cardiomyopathy
Fabio Fernandes
2012
View PDFchevron_right
Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide to Predict Clinical Course in Patients With Hypertrophic Cardiomyopathy
Elif Eroglu, Muzaffer Degertekin
The American Journal of Cardiology, 2006
View PDFchevron_right
The left atrial phasic functions and the relationship with plasma N-terminal pro-B-type natriuretic peptide levels and symptomatic states in patients with hypertrophic cardiomyopathy
Kamil Tuluce
Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology, 2014
View PDFchevron_right
Cardiac Multimarker Testing in Non-Obstructive Hypertrophic Cardiomyopathy
Radek Pudil
Military Medical Science Letters, 2016
View PDFchevron_right
Effect of omentin on cardiovascular functions and gene expressions in isolated rat hearts
özden Kutlay
The Anatolian Journal of Cardiology, 2018
View PDFchevron_right
Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
martin ortiz
Annals of Clinical Biochemistry, 2011
View PDFchevron_right
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial n...
Aldo Clerico, Michele Emdin
Clinical Chemistry and Laboratory Medicine, 2000
View PDFchevron_right
Evaluation of the association between serum uric acid level andthe predicted risk score of sudden cardiac death in five years in patients with hypertrophic cardiomyopathy
Muhammet Satilmisoglu
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2018
View PDFchevron_right
Biomarkers of Pathophysiology In Hypertrophic Cardiomyopathy: Implications for Clinical Management and Prognosis
Francisco Marín
European heart …, 2009
View PDFchevron_right
Use of B-type natriuretic peptide (BNP) as a rapid, point-of-care test for screening patients undergoing echocardiography for ventricular dysfunction
Nancy Gardetto
European Journal of Heart Failure, 2000
View PDFchevron_right
Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure
Torben Haghfelt
International Journal of Cardiology, 2006
View PDFchevron_right
Review on the Correlation between Natriuretic Peptide Levels and Heart Failure
IOSR Journals
View PDFchevron_right
Clinical analysis of 121 patients with hypertrophic cardiomyopathy
Di Yang
Journal of Nanjing Medical University, 2008
View PDFchevron_right
The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy
Vedide TAVLI
Bosnian Journal of Basic Medical Sciences, 2016
View PDFchevron_right
Higher copeptin levels are associated with worse outcome in patients with hypertrophic cardiomyopathy
Şükrü Çetin
Clinical Cardiology, 2016
View PDFchevron_right
Uric Acid as Prognostic Marker in Advanced Nonischemic Dilated Cardiomyopathy: Comparison With N-Terminal Pro B-Type Natriuretic Peptide Level
Chang-wook Nam
Congestive Heart Failure, 2010
View PDFchevron_right
Role of Plasma N-Terminal Pro-Brain Natriuretic Peptide (NT-Pro-BNP), a Diagnostic and Prognostic Biomarker of Acute Dyspnoea of Cardiac Diseases
Gautam Patnaik
Journal of Evolution of Medical and Dental Sciences, 2017
View PDFchevron_right
Brain natriuretic peptide--the biological marker in the diagnosis of overt congestive heart failure and myocardial ischemia
pavel babal
Bratislavske lekarske listy
View PDFchevron_right
Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death
Sergio Siqueira
Arquivos brasileiros de cardiologia, 2006
View PDFchevron_right
Addition of N-terminal Pro-B-type Natriuretic Peptide Levels to Electrocardiography Criteria for Detection of Left Ventricular Hypertrophy: The ARIRANG Study
Song Vogue Ahn
Journal of Korean medical science, 2015
View PDFchevron_right
Marked Elevation of Brain Natriuretic Peptide Levels in Pericardial Fluid Is Closely Associated With Left Ventricular Dysfunction
Yasuki Kihara
Journal of the American College of Cardiology, 1998
View PDFchevron_right
Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy
Thomas Manfredi
Toxicologic Pathology, 2016
View PDFchevron_right
Theranostic biomarkers in hypertrophic cardiomyopathy insights in a long road ahead
Gloria Bertoli
Frontiers in Bioscience
View PDFchevron_right
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors
Camillo Autore
The American Journal of Cardiology, 2014
View PDFchevron_right